Skip to main content
Log in

Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Chronic pain is common among patients with cirrhosis and is challenging to treat. While promising, pain self-management (PSM) interventions have not been tailored to this population’s needs.

Aims

To design a PSM intervention for patients with cirrhosis.

Methods

Semi-structured interviews with 17 patients with cirrhosis, 12 hepatologists, and 6 administrators from two medical centers were conducted to inform a rigorous, structured intervention mapping (IM) process. Qualitative content analysis was guided by social cognitive theory (SCT) and the Consolidated Framework for Implementation Research (CFIR) and incorporated into intervention development. A planning group met regularly throughout the intervention, to reach consensus about how to use data and theory to develop the intervention through IM.

Results

Participants described barriers to PSM behaviors, including the absence of simple, evidence-based interventions for pain for patients with cirrhosis, inadequate provider knowledge, time, and training, and lack of champions, funding, and communication. Patients described high motivation to treat pain using behavioral methods including meditation, prayer, and exercise. The intervention was designed to address barriers to PSM behaviors for patients with cirrhosis, using behavior change methods that address knowledge, self-efficacy, and outcome expectations. The LEAP (Liver Education About Pain) intervention is a 12-week, modular intervention delivered by phone via individual and group sessions with a health coach.

Conclusions

People with cirrhosis, hepatologists, and administrators informed this theory-driven, tailored PSM intervention, which was designed to be implementable in the real world.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Miller W, Crabtree BF. Primary care research: a multi typology and qualitative road map. In: Crabtree BF, Miller W, eds. Newbury Park, CA: Sage Publications; 1992; 3–28.

    Google Scholar 

  2. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010;138:513-521.e6.

    Article  PubMed  Google Scholar 

  3. Wong RJ, Liu B, Bhuket T. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011–2014 National Health and Nutrition Examination Survey. Aliment Pharmacol Ther 2017;46:974–980.

    Article  CAS  PubMed  Google Scholar 

  4. Beste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001–2013. Gastroenterology 2015;149:1471-1482.e5.

    Article  PubMed  Google Scholar 

  5. Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res 2017;17:88.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hardt J, Jacobsen C, Goldberg J, Nickel R, Buchwald D. Prevalence of chronic pain in a representative sample in the United States. Pain Med 2008;9:803–812.

    Article  PubMed  Google Scholar 

  7. Rogal SS, Beste L, Youk A et al. 898 - Opioid prescribing among veterans with cirrhosis. Gastroenterology 2018;154:S-1110.

    Article  Google Scholar 

  8. Rogal SS, Bielefeldt K, Wasan AD et al. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. Clin Gastroenterol Hepatol 2015;13:1009–1016.

    Article  PubMed  Google Scholar 

  9. Rogal SS, Bielefeldt K, Wasan AD, et al. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014.

  10. Rogal SS, Bielefeldt K, Wasan AD, Szigethy E, Lotrich F, DiMartini AF. Fibromyalgia symptoms and cirrhosis. Dig Dis Sci 2015;60:1482–1489.

    Article  CAS  PubMed  Google Scholar 

  11. Rogal SS, Winger D, Bielefeldt K, Szigethy E. Pain and opioid use in chronic liver disease. Dig Dis Sci 2013;58:2976–2985.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Klinge M, Coppler T, Liebschutz JM et al. The assessment and management of pain in cirrhosis. Curr Hepatol Rep 2018;17:42–51.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rogal SS, Winger D, Bielefeldt K, Rollman BL, Szigethy E. Healthcare utilization in chronic liver disease: the importance of pain and prescription opioid use. Liver Int 2013;33:1497–1503.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc 2010;85:451–458.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zedler B, Xie L, Wang L et al. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. Pain Med 2014;15:1911–1929.

    Article  PubMed  Google Scholar 

  16. Rogal SS, Landsittel D, Surman O, Chung RT, Rutherford A. Pretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation. Liver Transpl 2011;17:251–260.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Bergasa NV, Rothman RB, Mukerjee E, Vergalla J, Jones EA. Up-regulation of central mu-opioid receptors in a model of hepatic encephalopathy: a potential mechanism for increased sensitivity to morphine in liver failure. Life Sci 2002;70:1701–1708.

    Article  CAS  PubMed  Google Scholar 

  18. Acharya C, Betrapally NS, Gillevet PM et al. Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis. Aliment Pharmacol Ther 2017;45:319–331.

    Article  CAS  PubMed  Google Scholar 

  19. Rogal S, Mankaney G, Udawatta V et al. Association between opioid use and readmission following liver transplantation. Clin Transplant 2016;30:1222–1229.

    Article  CAS  PubMed  Google Scholar 

  20. Thiem A, Baumgartner M, Bol D. Still lost in translation! A correction of three misunderstandings between configurational comparativists and regressional analysts. Comp Polit Stud 2015;49:742–774.

    Article  Google Scholar 

  21. Department of Health and Human Services. National Pain strategy: a comprehensive population health strategy for pain. 2016. https://iprcc.nih.gov/docs/HHSNational_Pain_Strategy.pdf. Accessed September 27, 2021.

  22. Kroenke K, Bair MJ, Damush TM et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 2009;301:2099–2110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Merlin JS, Westfall AO, Long D et al. A randomized pilot trial of a novel behavioral intervention for chronic pain tailored to individuals with HIV. AIDS Behav 2018;22:2733–2742.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wilson M, Finlay M, Orr M et al. Engagement in online pain self-management improves pain in adults on medication-assisted behavioral treatment for opioid use disorders. Addict Behav 2018;86:130–137.

    Article  PubMed  Google Scholar 

  25. Merlin JS, Young SR, Johnson MO et al. Intervention mapping to develop a social cognitive theory-based intervention for chronic pain tailored to individuals with HIV. Contemp Clin Trials Commun 2018;10:9–16.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Eldridge LKB, Markham CM, Ruiter RAC, Fernandez ME, Kok G, Parcel GS. Planning Health Promotion Programs: An Intervention Mapping Approach. 4th Edition ed. San Francisco, CA: Jossey-Bass; 2016.

  27. Bartholomew LK, Parcel GS, Kok G, Gottleib NH, Fernandez ME. Planning health promotion programs: an intervention mapping approach, 2nd edn. San Francisco, CA: Jossey-Bass; 2011.

    Google Scholar 

  28. Ezeugwu VE, Manns PJ. Using intervention mapping to develop and implement a home-based sedentary behavior change intervention after stroke. Transl Behav Med. 2018.

  29. Huynh AK, Hamilton AB, Farmer MM et al. A pragmatic approach to guide implementation evaluation research: strategy mapping for complex interventions. Front Public Health 2018;6:134.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Jones TM, Dear BF, Hush JM, Titov N, Dean CM. Application of intervention mapping to the development of a complex physical therapist intervention. Phys Ther 2016;96:1994–2004.

    Article  PubMed  Google Scholar 

  31. Fernandez ME, Ten Hoor GA, van Lieshout S et al. Implementation mapping: using intervention mapping to develop implementation strategies. Front Public Health 2019;7:158.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977;84:191–215.

    Article  CAS  PubMed  Google Scholar 

  33. Bandura A. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs, N.J: Prentice-Hall; 1986.

    Google Scholar 

  34. Damschroder LJ, Lowery JC. Evaluation of a large-scale weight management program using the consolidated framework for implementation research (CFIR). Implement Sci 2013;8:51.

    Article  PubMed  PubMed Central  Google Scholar 

  35. CFIR Research Team. Consolidated framework of implementation research interview guide tool. 2018; http://www.cfirguide.org/guide/app/index.html#/. Accessed March 17, 2018.

  36. Kuzel AJ. Sampling in qualitative inquiry. In: Crabtree BF, Miller WL, eds. Newbury Park, CA: Sage Publications; 1992; 31–44.

    Google Scholar 

  37. Manchikanti L, Kaye AM, Knezevic NN et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: american society of interventional pain physicians (ASIPP) guidelines. Pain Physician 2017;20:S3–S92.

    Article  PubMed  Google Scholar 

  38. Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs 2008;62:107–115.

    Article  PubMed  Google Scholar 

  39. Rogal SS, Beste LA, Youk A et al. Characteristics of opioid prescriptions to veterans with cirrhosis. Clin Gastroenterol Hepatol 2019;17:1165-1174e3.

    Article  PubMed  Google Scholar 

  40. Rogal SS, Udawatta V, Akpan I et al. Risk factors for hospitalizations among patients with cirrhosis: a prospective cohort study. PLoS One 2017;12:e0187176.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Atici S, Cinel I, Cinel L, Doruk N, Eskandari G, Oral U. Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model. J Biosci 2005;30:245–252.

    Article  CAS  PubMed  Google Scholar 

  42. Chiang JK, Kao YH. Predictors of high healthcare costs in elderly patients with liver cancer in end-of-life: a longitudinal population-based study. BMC Cancer 2017;17:568.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Dwyer JP, Jayasekera C, Nicoll A. Analgesia for the cirrhotic patient: a literature review and recommendations. J Gastroenterol Hepatol 2014;29:1356–1360.

    Article  CAS  PubMed  Google Scholar 

  44. Moon AM, Jiang Y, Rogal SS, Tapper EB, Lieber SR, Barritt AS IV. Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis. Aliment Pharmacol Ther 2020;51:652–660.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Moon AM, Watkins SE, Lok AS, et al. Opioid use is more common in non-alcoholic fatty liver disease patients with cirrhosis, higher body mass index and psychiatric disease. Dig Dis. 2020.

  46. Merlin JS, Young SR, Johnson MO, et al. Using patient perspectives to inform the development of a behavioral intervention for chronic pain in patients with HIV: a qualitative study. Pain Med. 2016.

  47. Krebs EE, Lorenz KA, Bair MJ et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med 2009;24:733–738.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Kean J, Monahan PO, Kroenke K et al. Comparative RESPONSIVENESS of the PROMIS pain interference short forms, brief pain inventory, PEG, and SF-36 bodily pain subscale. Med Care 2016;54:414–421.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Weiner BJ, Lewis CC, Stanick C et al. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci 2017;12:108.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Stirman SW, Miller CJ, Toder K, Calloway A. Development of a framework and coding system for modifications and adaptations of evidence-based interventions. Implement Sci 2013;8:65.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Wilz G, Reder M, Meichsner F, Soellner R. The Tele.TAnDem intervention: telephone-based CBT for family caregivers of people with dementia. Gerontologist 2018;58:e118–e129.

    Article  PubMed  Google Scholar 

  52. Wilz G, Meichsner F, Soellner R. Are psychotherapeutic effects on family caregivers of people with dementia sustainable? Two-year long-term effects of a telephone-based cognitive behavioral intervention. Aging Ment Health 2017;21:774–781.

    Article  PubMed  Google Scholar 

  53. Lorig KR, Ritter PL, Laurent DD, Plant K. The internet-based arthritis self-management program: a one-year randomized trial for patients with arthritis or fibromyalgia. Arthritis Rheum 2008;59:1009–1017.

    Article  PubMed  Google Scholar 

  54. Nkhoma K, Norton C, Sabin C, Winston A, Merlin J, Harding R. Self-management interventions for pain and physical symptoms among people living with HIV: a systematic review of the evidence. J Acquir Immune Defic Syndr 2018;79:206–225.

    Article  PubMed  Google Scholar 

  55. Von Korff M, Moore JE, Lorig K et al. A randomized trial of a lay person-led self-management group intervention for back pain patients in primary care. Spine (Phila Pa 1976) 1998;23:2608–2615.

    Article  Google Scholar 

  56. Warsi A, LaValley MP, Wang PS, Avorn J, Solomon DH. Arthritis self-management education programs: a meta-analysis of the effect on pain and disability. Arthritis Rheum 2003;48:2207–2213.

    Article  PubMed  Google Scholar 

  57. Beg S, Curtis S, Shariff M. Patient education and its effect on self-management in cirrhosis: a pilot study. Eur J Gastroenterol Hepatol 2016;28:582–587.

    Article  PubMed  Google Scholar 

  58. Freundlich Grydgaard M, Bager P. Health literacy levels in outpatients with liver cirrhosis. Scand J Gastroenterol 2018;53:1584–1589.

    Article  PubMed  Google Scholar 

  59. Gulati R, Nawaz M, Pyrsopoulos NT. Health literacy and liver disease. Clin Liver Dis (Hoboken) 2018;11:48–51.

    Article  Google Scholar 

  60. Pinderup T, Bager P. Health literacy and liver cirrhosis: testing three screening tools for face validity. Br J Nurs 2019;28:441–445.

    Article  PubMed  Google Scholar 

  61. Scotten M. Parental health literacy and its impact on patient care. Prim Care 2015;42:1–16.

    Article  PubMed  Google Scholar 

  62. Barry CL, McGinty EE, Pescosolido BA, Goldman HH. Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness. Psychiatr Serv 2014;65:1269–1272.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Ahmedani BK. Mental health stigma: society, individuals, and the profession. J Soc Work Values Ethics 2011;8:4-1-4–16.

    Google Scholar 

  64. Allen B, Harocopos A, Chernick R. Substance use stigma, primary care, and the New York State prescription drug monitoring program. Behav Med 2020;46:52–62.

    Article  PubMed  Google Scholar 

  65. Shabanloei R, Ebrahimi H, Ahmadi F, Mohammadi E, Dolatkhah R. Stigma in cirrhotic patients: a qualitative study. Gastroenterol Nurs 2016;39:216–226.

    Article  PubMed  Google Scholar 

  66. Stringer KL, Baker EH. Stigma as a barrier to substance abuse treatment among those with unmet need: an analysis of parenthood and marital status. J Fam Issues 2018;39:3–27.

    Article  PubMed  Google Scholar 

  67. Tsai AC, Kiang MV, Barnett ML et al. Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLOS Med 2019;16:e1002969.

    Article  PubMed  PubMed Central  Google Scholar 

  68. van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend 2013;131:23–35.

    Article  PubMed  Google Scholar 

  69. Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, D.C.: National Academies Press (US); 2001.

  70. Tamirisa NP, Goodwin JS, Kandalam A et al. Patient and physician views of shared decision making in cancer. Health Expect 2017;20:1248–1253.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Muhlbacher AC, Juhnke C. Patient preferences versus physicians’ judgement: does it make a difference in healthcare decision making? Appl Health Econ Health Policy 2013;11:163–180.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, Department of Veterans Affairs, or the Government of the United States. We would like to thank the members of our planning group for their help and expertise.

Funding

This study was funded by AHRQ K12HS019461 and NIDA K23DA048182.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shari S. Rogal.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (TIF 1062 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rogal, S.S., Chinman, M.J., DeMonte, W. et al. Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis. Dig Dis Sci 67, 5063–5078 (2022). https://doi.org/10.1007/s10620-022-07380-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-022-07380-4

Keywords

Navigation